Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving Temozolomide
Clinical trial NCT01450826 · COMPLETED
Trial details
- NCT number
- NCT01450826
- Sponsor
- Katy Peters
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-24
- Primary completion
- 2017-04-13
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.